DILTIAZEM HYDROCHLORIDE INJECTION 5 MG
DILTIAZEM HYDROCHLORIDE : 5 MG · DIN 02244728 · SANDOZ CANADA INCORPORATED
Health Canada status: MARKETED
What is DILTIAZEM HYDROCHLORIDE INJECTION?
DILTIAZEM HYDROCHLORIDE INJECTION 5 MG contains DILTIAZEM HYDROCHLORIDE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02244728, held by SANDOZ CANADA INCORPORATED, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 15-Sep-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is DILTIAZEM HYDROCHLORIDE INJECTION called?
The same molecule, DILTIAZEM, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Diltiazem Sandoz CD | Latin | Australia |
| Vasocardol CD | Latin | Australia |
| ADIZEM | Latin | Morocco |
| PROGOR | Latin | Morocco |
| BI-TILDIEM LP | Latin | Morocco |
| Cardizem CD | Latin | Australia |
| MONO-TILDIEM LP | Latin | Morocco |
| Cardizem | Latin | Australia |
| TILDIEM | Latin | Morocco |
| Vasocardol | Latin | Australia |
| ALTIAZEM | Latin | Morocco |
| CRONODINE LP | Latin | Morocco |
| Dilatam | Latin | South Africa |
| DILRENE LP | Latin | Morocco |
| RETALZEM | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02244728 |
|---|---|
| Brand name | DILTIAZEM HYDROCHLORIDE INJECTION |
| Generic / active ingredient | DILTIAZEM HYDROCHLORIDE : 5 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 5 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | C08DB01 DILTIAZEM |
| AHFS class | 24:28.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 15-Sep-2005 |
| Original market date | 2002-01-09 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02244728 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2244728 |
| Brand name | DILTIAZEM HYDROCHLORIDE INJECTION |
| Active ingredient / INN | DILTIAZEM HYDROCHLORIDE : 5 MG |
| ATC code | C08DB01 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C08 |
| AHFS class | 24:28.92 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | SANDOZ CANADA INCORPORATED |
Which pack is which?
| Strength on the label | 5 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is DILTIAZEM in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C08DB01 DILTIAZEM. 75 of 175 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AA-DILTIAZ | 30 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00771376 |
| AA-DILTIAZ | 60 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00771384 |
| APO-DILTIAZ CD | 120 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | DIN 02230997 |
| APO-DILTIAZ CD | 180 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | DIN 02230998 |
| APO-DILTIAZ CD | 240 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | DIN 02230999 |
| APO-DILTIAZ CD | 300 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | DIN 02229526 |
| DILTIAZEM CD | 120 MG | CAPSULE (CONTROLLED-DELIVERY) | SANIS HEALTH INC | MARKETED | DIN 02400421 |
| DILTIAZEM CD | 120 MG | CAPSULE (EXTENDED RELEASE) | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02445999 |
| DILTIAZEM CD | 180 MG | CAPSULE (CONTROLLED-DELIVERY) | SANIS HEALTH INC | MARKETED | DIN 02400448 |
| DILTIAZEM CD | 180 MG | CAPSULE (EXTENDED RELEASE) | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02446006 |
Who else supplies DILTIAZEM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DILTIAZEM appears in 811 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does DILTIAZEM cost around the world?
DILTIAZEM is listed on 9 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Greece publishes a producer price (ex-factory); Italy publishes a prezzo al pubblico (classe A). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 21 | 135 | USD███.██ |
| Morocco | PPV (public price) | 12 | 27 | MAD███.██ |
| Italy | prezzo al pubblico (classe A) | 21 | 24 | EUR███.██ |
| Australia | ex-manufacturer | 5 | 20 | AUD███.██ |
| Greece | producer price (ex-factory) | 10 | 10 | EUR███.██ |
| Romania | max producer price | 5 | 6 | RON███.██ |
| South Africa | single exit price | 2 | 3 | ZAR███.██ |
| Slovakia | categorised final price | 2 | 2 | EUR███.██ |
| United Kingdom | hospital | 1 | 1 | GBP███.██ |
228 pack listings across 79 brand entries and 9 price bases, refreshed 08 Sep 2026. Ranges span every DILTIAZEM pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.